Want to keep learning?

This content is taken from the The University of Edinburgh & Royal College of Physicians of Edinburgh's online course, COVID-19 Critical Care: Understanding and Application. Join the course to learn more.

Skip to 0 minutes and 2 seconds[MACHINES BEEPING]

Skip to 0 minutes and 8 secondsWe're just coming around with our med biology colleagues just to get some expert advice on the treatment of your infection. OK. So this is Miss Ana Rogers. She's a 44-year-old lady who has been with us for five days now. On clinical treatment she comes from community acquired pneumonia on co-amoxiclav, clarithromycin, and oseltamivir with it being flu season. Clinically, she has improved a lot, though she's been lymphopenic through admission and occasionally, still a spike in the temperature. So we have positive results because the sputum from the 19th of January that is positive for Flu A, and that will correlate with the lymphopenia.

Skip to 0 minutes and 57 secondsAnd also, we've got a positive sputum sample that has a staph aureus, which on testing, is susceptible to flucloxacillin. Yeah. She doesn't seem to have any drug allergies. No, no known drug allergies. Very good. So we can probably continue with the oseltamivir. OK. And we can switch from amoxyclav to flucloxacillin. The sputum sample did not show any atypical organisms. So we can probably stop the clarithromycin. Excellent.

Skip to 1 minute and 36 secondsOK. And duration of flucloxacillin? In this context, probably seven days. OK. Good. Thanks very much. OK. Thank you. The next patient is--

Microbiology Ward Round

This video demonstrates a microbiology ward round on an intensive care unit.

Share this video:

This video is from the free online course:

COVID-19 Critical Care: Understanding and Application

The University of Edinburgh